MedPath

ifestyle program in treatment of Pompe disease. Combining exercise training and dietary intervention.

Completed
Conditions
Pompe's disease
Glycogen storage disease type II (GSD II)
Acid maltase deficiency.
10000546
10028302
Registration Number
NL-OMON50978
Lead Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
43
Inclusion Criteria

- Confirmed diagnosis of late onset Pompe disease measured by decreased acid a-
glucosidase activity in leukocytes or fibroblasts and also by mutation analysis.
- Diagnosis is made at the age of >= 1 years.
- Patients are >= 18 years of age.
- Patients sign an informed consent prior to participation.

Exclusion Criteria

- Any concurrent medical condition interfering with participation in a
lifestyle program.
- Participation in studies on alternative enzyme replacement therapy.
- Treatment with usual care enzyme replacement therapy, (Myozyme ®, Genzyme)
for >1 and <52 weeks.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath